Steven E. Nissen

Cleveland Clinic — United States

Medicine · Health Sciences

63h-index21.9kcitations196works18.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(99), Cardiac Imaging and Diagnostics(80), Coronary Interventions and Diagnostics(78), Diabetes, Cardiovascular Risks, and Lipoproteins(23), Cerebrovascular and Carotid Artery Diseases(21)

Publications196 total

Cholesterol management in US adults with ASCVD in the Family Heart Database® during 2022–23: Current state of care and opportunities for improvement
American Journal of Preventive Cardiology·2025Open Access
Abstract 4359241: Cholesterol Management in US Individuals with ASCVD within the Family Heart Database <sup>®</sup> during 2022/23: Current State of Care and Opportunities for Improvement
Circulation·2025
Abstract 4358653: Effects of Bempedoic Acid on Venous Thromboembolism: a Post-Hoc Analysis of The CLEAR Outcomes Trial
Circulation·2025
Abstract 4366848: Advance-HTN Trial Participant Characteristics Associated with a Failure to be Randomized
Circulation·2025
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks
JACC. Cardiovascular imaging·2025· 1 cited
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Heart Journal·2025· 169 citedOpen Access
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial
American Journal of Cardiovascular Drugs·2025· 1 citedOpen Access
† Safety and efficacy of obicetrapib in patients with heterozygous familial hypercholesterolemia
Journal of clinical lipidology·2025· 1 cited
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial
American Heart Journal·2025· 4 cited
Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis
European Journal of Preventive Cardiology·2025· 3 cited
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
American Heart Journal·2025· 65 citedOpen Access
EFFICACY AND SAFETY OF BEMPEDOIC ACID IN PATIENTS ≥75 YEARS: ANALYSIS OF CLEAR OUTCOMES
Journal of the American College of Cardiology·2025· 1 citedOpen Access
Testosterone Replacement Therapy and Risk of COVID-19 and Effect of COVID-19 on Testosterone's Treatment Effect
Journal of the Endocrine Society·2025· 5 citedOpen Access
Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions With Automated Assessments in Hypertrophic Cardiomyopathy: A Substudy From VALOR-HCM
Journal of the American Society of Echocardiography·2024
Oral Muvalaplin for Lowering of Lipoprotein(a)
JAMA·2024· 89 citedOpen Access
Abstract 4120785: Differential Cardiovascular Impact of ω-3 Fatty Acid in Patients at High Cardiovascular Risk in Asians versus non-Asians: Sub-analysis of the STRENGTH Randomized Clinical Trial
Circulation·2024
Abstract 4146592: Device-Recorded Physical Activity and Atrial Fibrillation Burden: A Natural History Experiment from the COVID-19 Pandemic in the TRIM-AF Clinical Trial
Circulation·2024
What We Have Learned About Reducing Low-Density Lipoprotein Cholesterol and Coronary Plaques
JAMA Cardiology·2024· 1 cited
Impact of the COVID‐19 Pandemic on Conduct and Results of CLEAR Outcomes Trial
Clinical Cardiology·2024· 3 citedOpen Access
Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs
Journal of the American College of Cardiology·2024· 24 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Stephen J. Nicholls(40), E. Murat Tuzcu(20), Christie M. Ballantyne(15), John J.P. Kastelein(15), Kathy Wolski(13), Paul Schoenhagen(10), Rishi Puri(10), Kiyoko Uno(9), Wolfgang Köenig(8), Philip J. Barter(8), Samir Kapadia(8), İlke Sipahi(7), Kathy Wolski(7), Marilyn Borgman(7), Mingyuan Shao(7), Yu Kataoka(7), Jean‐Claude Tardif(6), A. Michael Lincoff(6), Peter Libby(5), Danielle M. Brennan(5)